Inactief instrument

Andere talen VIVUS, Inc.

Aandelen

VVUSQ

US9285513084

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

VIVUS LLC Announces It Will Provide Telehealth to Patients Through an Enhanced 'Engage' Program in Collaboration with UpScriptHealth	22/04
VIVUS LLC Announces Positive Topline Data from a Post-Marketing Study to Evaluate the Effect of QSYMIA	28/11
VIVUS, Inc. Promotes Santosh T. Varghese to President VIVUS Global Pharmaceutical Development	10-01-23
FDA Approves VIVUS LLC's QSYMIA® for the Treatment of Obesity in Adolescents Ages 12-17	20-07-22
VIVUS : Receives Court Approval of Joint Chapter 11 Plan of Reorganization	14-12-20
VIVUS, Inc. Emerged from Bankruptcy	11-12-20
Revised Second Amended Reorganization Plan & Disclosure Statement Approved for VIVUS, Inc.	10-12-20
First Motion for Exclusivity Period Extension Approved For VIVUS, Inc.	17-11-20
VIVUS : Seeks Bankruptcy Court Approval of Second Amended Joint Chapter 11 Plan of Reorganization and Existing Stock Record Date	16-11-20
VIVUS INC : Other Events, Financial Statements and Exhibits (form 8-K)	16-11-20
Second Amended Joint Pre-Packaged Reorganization Plan Filed by VIVUS, Inc.	10-11-20
First Motion for Exclusivity Period Extension Filed by VIVUS, Inc.	04-11-20
Motion for Asset Sale Filed by VIVUS, Inc.	20-10-20
First Amended Joint Pre-Packaged Reorganization Plan Filed by VIVUS, Inc.	18-08-20
VIVUS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure (form 8-K)	13-07-20
VIVUS, Inc.(NasdaqGS:VVUS) dropped from S&P TMI Index	10-07-20
Motion for Joint Administration Approved for VIVUS, Inc.	10-07-20
Combined Hearing for Disclosure Statement and Plan Approved for VIVUS, Inc.	10-07-20
Health Care Flat As Growth Investors Seek Out Tech -- Health Care Roundup	08-07-20
VIVUS INC : Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	07-07-20

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen VIVUS, Inc.

Aandelen

VVUSQ

US9285513084

Andere talen

Filters